E-Submission
Yeungnam University College of MedicineIndexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
Search
- Page Path
- HOME > Search
Review Article
- Pediatrics, Perinatology, and Child Health
- Short Stature and Growth Hormone Therapy.
- Yong Hoon Park
- Yeungnam Univ J Med. 2005;22(1):1-12. Published online June 30, 2005
- DOI: https://doi.org/10.12701/yujm.2005.22.1.1
- 4,170 View
- 16 Download
- 1 Crossref
-
Abstract
PDF - Normal growth and development is of prime concern during childhood. The treatment of children with growth hormone deficiency has been revolutionized by growth hormone therapy. An improved height outcome with a final height within the target height range has been achieved. However, close follow-up with regular clinical and laboratory monitoring is essential for achieving the desirable height outcome. The theoretical unlimited supply of growth hormone has led to its wide spread use in a variety of disorders other than a growth hormone deficiency. Initially used in children with Turner syndrome, growth hormone is now used to treat chronic renal failure, an idiopathic short stature and intrauterine growth restrictions in addition to a wide array of newly emerging indications. This review summarizes the basics for a proper growth assessment, the differentiation of normal and abnormal growth causes of a short stature, and the indications for growth hormone treatment.
-
Citations
Citations to this article as recorded by
- Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment
Hyun Wook Chae, Il-Tae Hwang, Ji-Eun Lee, Cheol Hwan So, Young-Jun Rhie, Jung Sub Lim, Eun Byul Kwon, Kyung Hee Yi, Eun Young Kim, Chae-Ku Jo, Kye Shik Shim, Ha-Yeong Gil, Min-Jeong Seong, Chung Mo Nam, Ji-Su Moon, Jin Soon Hwang
Frontiers in Endocrinology.2022;[Epub] CrossRef
- Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment
First
Prev
